ResearcherOsaka International Cancer InstituteActive in the last 2 years
Hisataka Ogawa
Matched on ORCID iD 0000-0002-9317-5007; OpenAlex author ID A5065529459. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routin… Co-author DOI 10.1007/s12094-025-04111-9↗
- Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic ca… Co-author DOI 10.1055/a-1713-3404↗
- The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Co-author DOI 10.3892/mco.2015.490↗
- [Three Resected Cases of Metachronous Pancreatic Cancer Successfully Treated with Repeated Pancreatectomy]. Co-author PMID 26805359↗
- Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma. First author DOI 10.1016/j.surg.2011.03.001↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hidenori Takahashi · 3 shared papers, 2011–2026 · strength 0.40
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Paper Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarc… DOI 10.1016/j.surg.2011.03.001↗
- Kenji Ikezawa · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Shinichiro Hasegawa · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Ryoji Takada · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Yugo Kai · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Tomoya Ekawa · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Shigenori Nagata · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Hideaki Tahara · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Kazuyoshi Ohkawa · 2 shared papers, 2022–2026 · strength 0.38
- Paper Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived fro… DOI 10.1007/s12094-025-04111-9↗
- Paper Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle a… DOI 10.1055/a-1713-3404↗
- Yoji Kukita · 1 shared paper, 2026 · strength 0.25
- Makiko Urabe · 1 shared paper, 2026 · strength 0.25
- Nobuyasu Fukutake · 1 shared paper, 2022 · strength 0.13
- Takuo Yamai · 1 shared paper, 2022 · strength 0.13
- Yuichiro Doki · 2 shared papers, 2015 · strength 0.08
- Hidetoshi Eguchi · 2 shared papers, 2015 · strength 0.08
- Yoshito Tomimaru · 2 shared papers, 2015 · strength 0.08
- Shigeru Marubashi · 2 shared papers, 2015 · strength 0.08
- Hiroaki Nagano · 2 shared papers, 2015 · strength 0.08
- Kozo Noguchi · 1 shared paper, 2015 · strength 0.04
- Masaki Mori · 1 shared paper, 2015 · strength 0.04
- Tadafumi Asaoka · 1 shared paper, 2015 · strength 0.04
- Daisaku Yamada · 1 shared paper, 2015 · strength 0.04
- Hideshi Ishii · 1 shared paper, 2015 · strength 0.04
- Satoaki Nakamura · 1 shared paper, 2011 · strength 0.02
- Masahiko Yano · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.